SCM
RETA

Silverarc Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Silverarc Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,500
Closed -$1.27M – 94
2023
Q2 		$1.27M Buy
+12,500
New +$1.27M 0.39% 50
2021
Q3 		– Sell
-9,346
Closed -$1.32K – 107
2021
Q2 		$1.32K Buy
+9,346
New +$1.32K 0.59% 57